The purpose of this study is to develop and evaluate a computer-based decision aid (DA) for use by men considering prostate-specific antigen (PSA) screening for prostate cancer. Major medical organizations recommend that men discuss the risks and benefits of this test with their physician before making the decision. This educational, interactive DA will help them prepare for that discussion.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of Patients Who Were Ready to Make a Decision or Were Undecided
Timeframe: Assessed at baseline and follow-up, up to 10 months
Percentage of Correct Responses in Assessing Mens' Recognition of the Prostate-specific Antigen Test and Knowledge Related to Prostate-cancer Topics.
Timeframe: Assessed at baseline and follow-up, up to 10 months
Mean and Standard Error of a Scale Used to Assess Men's Confidence Level in Making Decisions Related to Prostate Cancer Screening.
Timeframe: Assessed at baseline and follow-up, up to 10 months
Percentage of Consistency Between Screening Preference and Personal Values Relevant to the Screening Decision
Timeframe: Assessed at baseline and follow-up, up to 10 months